
Iyi ngingo itanga incamake yiterambere rigezweho muri Ubushinwa buvura kanseri y'ibihaha, ikubiyemo uburyo bushya bwo kuvura, ubushakashatsi bwakozwe, no kugera ku buhanga bugezweho bwo kuvura. Dushakisha uburyo butandukanye bwo kuvura, tuganira ku mikorere yabyo, tunagaragaza imbaraga zikomeje kunoza umusaruro w’abarwayi. Aya makuru agenewe intego zuburezi kandi ntizigomba gufatwa nkinama zubuvuzi. Buri gihe ujye inama ninzobere mu buvuzi kugirango ubone ubuyobozi bwihariye.
Ubuvuzi bugamije burimo guhinduka Ubushinwa buvura kanseri y'ibihaha mukwibanda ku ihinduka ryimiterere yihariye itera kanseri ikura. Iyi miti ikora ihagarika ibikorwa byizo poroteyine zidasanzwe, bityo bikabuza gukura kwikibyimba no kuramba. Ingero zirimo EGFR tyrosine kinase inhibitor (TKIs) nka gefitinib na erlotinib, iboneka cyane mubushinwa. Ingaruka ziyi miti ziterwa numwirondoro wihariye wibibyimba, bisaba kwipimisha byuzuye.
Immunotherapy ikoresha imbaraga za sisitemu yumubiri yumubiri kugirango irwanye kanseri. Immune igenzura (ICIs), nka pembrolizumab na nivolumab, ikoreshwa cyane muri Ubushinwa buvura kanseri y'ibihaha. Iyi miti ibuza poroteyine zibuza sisitemu y’umubiri kwibasira kanseri ya kanseri, bigatuma ishobora kwibasira ikibyimba neza. Igeragezwa ry’amavuriro mu Bushinwa rikomeje gusuzuma imikorere n’umutekano by’ubwo buvuzi mu bwoko butandukanye bwa kanseri y'ibihaha.
Chimoterapi ikomeza kuba umusingi wa Ubushinwa buvura kanseri y'ibihaha, gukoresha imiti ikomeye yo kwica kanseri. Nubwo bishobora kugira ingaruka zikomeye, iterambere ryatumye habaho kunoza itangwa ryibiyobyabwenge no kugabanya uburozi. Guhitamo imiti ya chimiotherapie biterwa nibintu bitandukanye, harimo kanseri, ubuzima muri rusange, hamwe nibyo abarwayi bakunda. Mu Bushinwa, kubona imiti itandukanye ya chimiotherapie biratera imbere, hamwe n’ingamba zikomeje gukorwa kugira ngo bigerweho ku gihe kandi bihendutse.
Radiotherapy ikoresha imirasire yingufu nyinshi kugirango yice selile. Ubuhanga bugezweho, nka radiotherapi (IMRT) hamwe na radioterapi yumubiri wa stereotactique (SBRT), bituma habaho kwibasira neza ibibyimba, bikagabanya kwangirika kwinyama nzima. Ubu buryo bugezweho bwa radiotherapi buragenda buboneka mubitaro bikuru byo mu Bushinwa, bigira uruhare runini mu kuvura abarwayi ba kanseri y'ibihaha.
Sisitemu y’ubuzima y’Ubushinwa igenda igezweho vuba, itanga uburyo bunoze bwo kugera ku iterambere Ubushinwa buvura kanseri y'ibihaha amahitamo. Ibitaro byinshi bikomeye mu mijyi minini bitanga ubuvuzi bwuzuye bwa kanseri, harimo ibikoresho bigezweho, abahanga mu bumenyi bwa oncologue, ndetse no kubona imiti igezweho. Mu gihe ubudasa butandukanye bwo kuboneka bushobora kubaho, hari intambwe igaragara irimo gukorwa kugira ngo ubuvuzi bwa kanseri bufite ireme mu gihugu hose. Kugirango ubuvuzi bwuzuye bwa kanseri, tekereza gushakisha uburyo bwo kuyobora ibigo nka Shandong Baofa Ikigo Cyubushakashatsi Kanseri.
Ubushakashatsi muri Ubushinwa buvura kanseri y'ibihaha irakomeje, hamwe nabahanga nabashakashatsi bahora baharanira guteza imbere uburyo bwiza bwo kuvura uburozi. Igeragezwa rya Clinical ririmo gusuzuma imiti mishya, uburyo bwo kuvura udushya, hamwe n’ingamba z’ubuvuzi bwihariye zijyanye na geneti ya buri muntu. Iterambere rifite isezerano ryiterambere ryinshi mubikorwa byo kuvura kanseri yibihaha mumyaka iri imbere.
Ibisobanuro byatanzwe muriyi ngingo bigenewe intego zuburezi gusa kandi ntibigomba gufatwa nkinama zubuvuzi. Buri gihe ujye ubaza inzobere mu by'ubuzima zujuje ibisabwa kugira ngo zisuzume kandi zivure indwara iyo ari yo yose.